ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
60 hedge funds and large institutions have $70.5M invested in Zynerba Pharmaceuticals, Inc in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 2 closing their positions.
Holders
60
Holders Change
+26
Holders Change %
+76.47%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
16
Reduced
9
Closed
2
Calls
$10.7M
Puts
$8.4M
Net Calls
+$2.33M
Net Calls Change
-$1.03M
Top Buyers
1 |
MWNA
1
Marshall Wace North America
New York
|
$9.36M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$6.77M |
3 |
3
BlackRock
New York
|
$3.99M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$8.56M |
5 |
SFM
5
Sphera Funds Management
Tel Aviv,
Israel
|
$2.01M |